Revefenacin Patents

Given below is the list of patents protecting Revefenacin, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Revefenacin's patents.

Latest Legal Activities on Revefenacin's Patents

Given below is the list recent legal activities going on the following patents of Revefenacin.

Activity	Date	Patent Number
Legal Activities for all Patents
Email Notification Critical	03 May, 2024	US7585879
Change in Power of Attorney (May Include Associate POA) Critical	03 May, 2024	US7585879
Email Notification Critical	25 Apr, 2024	US7288657
Change in Power of Attorney (May Include Associate POA) Critical	25 Apr, 2024	US7288657
Payment of Maintenance Fee, 12th Year, Large Entity	25 Mar, 2024	US8273894
Notice of Final Determination -Election Required	22 Mar, 2024	US7585879
Notice of Final Determination -Election Required	22 Mar, 2024	US7288657
Recordation of Patent eCertificate of Correction	20 Feb, 2024	US11858898
Mail Patent eCofC Notification	20 Feb, 2024	US11858898
Email Notification Critical	20 Feb, 2024	US11858898

Revefenacin's Family Patents

Full family tree

Explore Our Curated Drug Screens